Tuesday, October 27, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 3, 2026

Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus)

View original at nasdaq.com
Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus) Key Points Nearly a quarter-century of Gallup surveys show that Social Security income is relied upon by up to 90% of retirees to make ends meet…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Claiming at age 62 can permanently reduce a worker's monthly payout by 25% to 30%, depending on their birth year

    60% confidence
  • Up to 90% of retirees rely on Social Security income to make ends meet

    60% confidence
  • Spending more time out of the labor force has negatively impacted the earning potential for women, resulting in the observed drop-off in average retired-worker payouts from age 85 onward

    60% confidence
  • One easy trick could pay you as much as $23,760 more each year in Social Security benefits

    60% confidence
  • Waiting until age 70 to initially collect benefits can increase their benefit by 24% to 32% above what they'd receive at full retirement age

    60% confidence
  • 26% of mothers were stay-at-home parents compared to just 7% of fathers

    60% confidence
  • 80% to 90% of retirees rely on their Social Security payout to cover some portion of their expenses

    60% confidence
  • For every year a worker waits to initially collect their benefit, from age 62 until age 70, their payout can grow by up to 8%

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus) — Source | Via News | ViaNews Market